WaferGen Bio-systems, Inc. Sustainability Profile
WaferGen Bio-systems, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 2001, the company has established itself as a key player in genomic analysis and molecular diagnostics, focusing on advanced solutions for personalised medicine and research applications. WaferGen's core offerings include the SmartChip™ Real-Time PCR System and the SmartChip™ technology, which enable high-throughput gene expression analysis with unparalleled accuracy and efficiency. These unique products set WaferGen apart in the competitive landscape, catering to both academic and commercial laboratories. With a commitment to advancing genomic research, WaferGen has achieved significant milestones, positioning itself as a trusted partner in the life sciences industry. Its innovative approach continues to drive growth and enhance its reputation in the global market.
DitchCarbon Score
How does WaferGen Bio-systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
WaferGen Bio-systems, Inc.'s score of 33 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
WaferGen Bio-systems, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Takara Bio Inc., which may influence its climate commitments and reporting practices. As of now, WaferGen has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may be in the early stages of developing its climate strategy. Given its relationship with Takara Bio Inc., emissions data and climate initiatives may be cascaded from this parent company, which operates at a higher level in the corporate structure. However, specific details regarding Takara Bio Inc.'s emissions performance or climate commitments have not been provided in this context. In summary, while WaferGen Bio-systems, Inc. does not currently report emissions data or reduction targets, its affiliation with Takara Bio Inc. may play a role in shaping its future climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - |
| Scope 2 | - | - | - | - | - | - |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is WaferGen Bio-systems, Inc.'s Industry?
How Carbon Intensive is WaferGen Bio-systems, Inc.'s Location?
WaferGen Bio-systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
WaferGen Bio-systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
